Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder?
- Paul J. Fitzgerald, Chris Barkus, +13 authors A. J. Holmes
- Neurobiology of Disease
- 2010
Highly Influenced
5 Excerpts
Antagonism of AMPA receptors produces anxiolytic-like behavior in rodents: Effects of GYKI 52466 and its novel analogues
@article{Kapus2008AntagonismOA,
title={Antagonism of AMPA receptors produces anxiolytic-like behavior in rodents: Effects of GYKI 52466 and its novel analogues},
author={G{\'a}bor L. Kapus and Istv{\'a}n Gacs{\'a}lyi and Miklos G. Vegh and Hajnalka Kompagne and Endre Hegedűs and Csilla Leveleki and L{\'a}szl{\'o} G{\'a}bor H{\'a}rsing and J{\'o}zsef Bark{\'o}czy and Andras Bilkei-Gorzo and Gy{\"o}rgy L{\'e}vay},
journal={Psychopharmacology},
year={2008},
volume={198},
pages={231-241}
}- Published in Psychopharmacology 2008
DOI:10.1007/s00213-008-1121-z
Although emerging number of data supports the role of glutamate receptors and the potential of their antagonists in anxiety disorders, the involvement of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate receptors in anxiety is less well characterized. To evaluate the anxiolytic potential of 2,3-benzodiazepine (2,3BDZ) type AMPA receptor antagonists in various models of anxiety. Whole-cell currents, hippocampal field potentials, elevated plus maze (EPM), meta… CONTINUE READING